Current Psychiatry Reports

, Volume 13, Issue 5, pp 357–363

Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications

  • Paul G. Hammerness
  • Craig B. H. Surman
  • Ashley Chilton
Article

DOI: 10.1007/s11920-011-0213-3

Cite this article as:
Hammerness, P.G., Surman, C.B.H. & Chilton, A. Curr Psychiatry Rep (2011) 13: 357. doi:10.1007/s11920-011-0213-3

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobehavioral disorder afflicting adults worldwide. This article is an update on the evidence supporting medications for adult ADHD, with particular emphasis on cardiovascular implications. Relevant clinical literature was sought using PubMed searches, with an emphasis on new reports from April 2009 to April 2011. This review describes the efficacy and general tolerability of stimulant and nonstimulant medications for adults with ADHD as seen in contemporary clinical trials. Cardiovascular response to medications for ADHD is primarily seen in heart rate and blood pressure elevations, while less is known about the etiology of rare cardiovascular events or long-term sequelae. Further research is indicated to delineate clinical and functional outcomes for adults with ADHD, as well as long-term safety of medication treatment.

Keywords

ADHD Treatment Adult Medication Stimulant Cardiovascular 

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Paul G. Hammerness
    • 1
  • Craig B. H. Surman
    • 1
  • Ashley Chilton
    • 1
  1. 1.Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHDMassachusetts General Hospital and Harvard University Medical SchoolCambridgeUSA

Personalised recommendations